Skip to main content

Soo Han Bae

Yonsei University · 生化学・遺伝学・分子生物学

研究室紹介

Professor Soo Han Bae's research lab focuses on the molecular mechanisms underlying oxidative stress and cellular defense pathways in liver diseases, particularly nonalcoholic fatty liver disease (NAFLD) and alcoholic liver injury. The lab investigates the roles of key redox regulators such as the Nrf2/KEAP1 pathway, peroxiredoxins (Prxs), and sulfiredoxin (Srx) in maintaining cellular homeostasis under stress conditions. A central theme is the interplay between oxidative stress, mitochondrial dysfunction, and autophagy in hepatocyte survival and death. The lab also explores therapeutic strategies targeting the gut-liver axis and dual hormone receptor agonists for metabolic liver diseases.

oxidative stressNrf2 pathwayliver diseaseperoxiredoxinautophagy

Research Overview

Papers
71
Total Citations
12,429
Papers (5y)
21
Primary Field
生化学・遺伝学・分子生物学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
21total
2022
2023
2024
2025
2026
Citations per year (5y)
296total
20222023202420252026

Selected Papers

15
1
Article|489 citations·2012
Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage
Soo Han Bae, Su Haeng Sung, Sue Young Oh, Jung Mi Lim, Se Kyoung Lee, Young Nyun Park, Hye Eun Lee, Dongmin Kang, Sue Goo Rhee
SJR Q1Cell MetabolismOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
2
Article|252 citations·2020
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity
Da Hyun Lee, Jeong Su Park, Yu Seol Lee, Jisu Han, Dong‐Kyu Lee, Sung Won Kwon, Dai Hoon Han, Yong‐ho Lee, Soo Han Bae
SJR Q1AutophagyOA

Lipotoxicity, induced by saturated fatty acid (SFA)-mediated cell death, plays an important role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). The KEAP1 (kelch like ECH associated protein 1)-NFE2L2/NRF2 (nuclear factor, erythroid 2 like 2) pathway is a pivotal defense mechanism against lipotoxicity. We previously reported that SQSTM1/p62 has a cytoprotective role against lipotoxicity through activation of the noncanonical KEAP1- NFE2L2 pathway in hepatocytes. However, the unde

Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Review|140 citations·2015
The antioxidant function of sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1
Sue Goo Rhee, Soo Han Bae
SJR Q1Free Radical Biology and MedicineOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
4
Article|92 citations·2010
Concerted Action of Sulfiredoxin and Peroxiredoxin I Protects Against Alcohol-Induced Oxidative Injury in Mouse Liver σ
Soo Han Bae, Su Haeng Sung, Eun‐Jung Cho, Se Kyoung Lee, Hye Eun Lee, Hyun Ae Woo, Dae‐Yeul Yu, In Sup Kil, Sue Goo Rhee
SJR Q1HepatologyOA

UNLABELLED: Peroxiredoxins (Prxs) are peroxidases that catalyze the reduction of reactive oxygen species (ROS). The active site cysteine residue of members of the 2-Cys Prx subgroup (Prx I to IV) of Prxs is hyperoxidized to cysteine sulfinic acid (Cys-SO(2) ) during catalysis with concomitant loss of peroxidase activity. Reactivation of the hyperoxidized Prx is catalyzed by sulfiredoxin (Srx). Ethanol consumption induces the accumulation of cytochrome P450 2E1 (CYP2E1), a major contributor to et

Molecular BiologyBiochemistry, Genetics and Molecular Biology
5
Article|75 citations·2021
A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, In Jeong Oh, Da Hyun Choi, Yu Seol Lee, Yu seol Lee, I Seul Park, SeungWon Kim, Da Hyun Lee, Jae Hee Cheon
SJR Q1HepatologyOA

BACKGROUND AND AIMS: Currently there is no Food and Drug Administration-approved drug to treat NAFLD and NASH, the rates of which are increasing worldwide. Although NAFLD/NASH are highly complex and heterogeneous conditions, most pharmacotherapy pipelines focus on a single mechanistic target. Considering the importance of the gut-liver axis in their pathogenesis, we investigated the therapeutic effect of a long-acting dual agonist of glucagon-like peptide (GLP)-1 and GLP-2 receptors in mice with

Endocrinology, Diabetes and MetabolismMedicine
6
Article|53 citations·2008
Induction of Sulfiredoxin via an Nrf2-Dependent Pathway and Hyperoxidation of Peroxiredoxin III in the Lungs of Mice Exposed to Hyperoxia
Soo Han Bae, Hyun Ae Woo, Su Haeng Sung, Hye Eun Lee, Se Kyoung Lee, In Sup Kil, Sue Goo Rhee
SJR Q1Antioxidants and Redox SignalingOA

The cysteine residue at the active site of peroxiredoxin (Prx) I, Prx II, or Prx III is reversibly hyperoxidized to cysteine sulfinic acid, with concomitant loss of peroxidase activity, during normal catalysis. Sulfiredoxin (Srx) is the enzyme responsible for reversing this hyperoxidation. We now show that the expression of Srx at both the mRNA and protein levels is increased markedly in the lungs of mice exposed to hyperoxia. This hyperoxia-induced expression of Srx was not evident in mice defi

Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Article|52 citations·2012
Peroxiredoxin III and Sulfiredoxin Together Protect Mice from Pyrazole-Induced Oxidative Liver Injury
Soo Han Bae, Su Haeng Sung, Hye‐Eun Lee, Ha Tan Kang, Se Kyoung Lee, Sue Young Oh, Hyun Ae Woo, In Sup Kil, Sue Goo Rhee
SJR Q1Antioxidants and Redox Signaling

AIMS: To define the mechanisms underlying pyrazole-induced oxidative stress and the protective role of peroxiredoxins (Prxs) and sulfiredoxin (Srx) against such stress. RESULTS: Pyrazole increased Srx expression in the liver of mice in a nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent manner and induced Srx translocation from the cytosol to the endoplasmic reticulum (ER) and mitochondria. Pyrazole also induced the expression of CYP2E1, a primary reactive oxygen species (ROS) source

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|50 citations·2019
Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity
Jeong Su Park, Da Hyun Lee, Yu Seol Lee, Eunji Oh, Kwang‐Hee Bae, Kyoung‐Jin Oh, Hyun-Mi Kim, Soo Han Bae
SJR Q1AutophagyOA

Saturated fatty acid (SFA)-induced lipotoxicity is caused by the accumulation of reactive oxygen species (ROS), which is associated with damaged mitochondria. Moreover, lipotoxicity is crucial for the progression of nonalcoholic steatohepatitis (NASH). Autophagy is required for the clearance of protein aggregates or damaged mitochondria to maintain cellular metabolic homeostasis. The NFE2L2/NRF2 (nuclear factor, erythroid 2 like 2)-KEAP1 (kelch like ECH associated protein 1) pathway is essential

Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|41 citations·2022
PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway
Da Hyun Lee, Jeong Su Park, Yu Seol Lee, Soo Han Bae
SJR Q1Redox BiologyOA

Hepatic lipotoxicity is a crucial factor in nonalcoholic steatohepatitis resulting from excessive saturated fatty acid-induced reactive oxygen species (ROS)-mediated cell death, which is associated with the accumulation of endoplasmic reticulum (ER) stress in the liver. The unfolded protein response (UPR) alleviates ER stress by restoring ER protein folding homeostasis. However, whether UPR contributes ROS elimination under lipotoxicity remains unclear. The Kelch like ECH-associated protein 1 (K

Molecular BiologyBiochemistry, Genetics and Molecular Biology
10
Article|37 citations·2017
The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity
Da Hyun Lee, Jeong Su Park, Yu Seol Lee, Su Haeng Sung, Yong‐ho Lee, Soo Han Bae
SJR Q1BMB ReportsOA

Nuclear factor erythroid 2-related factor 2 (Nrf2) provides a cellular defense against oxidative stress by inducing the expression of antioxidant and detoxification enzymes. The calcium antagonist, verapamil, is an FDA-approved drug prescribed for the treatment of hypertension. Here, we show that verapamil acts as a potent Nrf2 activator without causing cytotoxicity, through degradation of Kelch-like ECH-associated protein 1 (Keap1), a Nrf2 repressor. Furthermore, verapamilinduced Keap1 degradat

Molecular BiologyBiochemistry, Genetics and Molecular Biology
11
Article|37 citations·2019
Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model
Jung Bok Lee, Jeong Su Park, Young Min Shin, Da Hyun Lee, Jeong‐Kee Yoon, Dae‐Hyun Kim, Ung Hyun Ko, YongTae Kim, Soo Han Bae, Hak‐Joon Sung
SJR Q1Advanced Functional MaterialsOA

Abstract Artificial liver models have been extensively developed for pathological modeling and toxicological studies. However, the prediction of existing in vitro liver models rarely corresponds to what is consequently observed in vivo owing to the structural and functional complexity of the liver. Here, a new liver model designed to enable the implantation and maintenance of liver buds in perfusable 3D hydrogels where a microvascular network develops within a 200 µm diffusion limit is developed

HepatologyMedicine
12
Article|37 citations·2018
CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes
Eugene Chang, Dae‐Hee Kim, Hyekyung Yang, Da Hyun Lee, Soo Han Bae, Cheol‐Young Park
SJR Q1PLoS ONEOA

Previous studies have shown that the CB1 receptor antagonist reverses steatohepatitis and its related features of metabolic syndrome, such as obesity and type 2 diabetes. However, the beneficial effects of CB1 receptor blockade on hepatic steatosis and inflammation have not been investigated independently of its effects on body weight and glycemic control. At 32 weeks of age, OLETF rats were administered with rimonabant (10 mg·kg-1·day-1) by oral gavage for 6 weeks. No significant changes in bod

PharmacologyMedicine
13
Article|36 citations·2015
Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity
Jeong Su Park, Dong Hoon Kang, Da Hyun Lee, Soo Han Bae
SJR Q2Biochemical and Biophysical Research CommunicationsOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
14
Article|32 citations·2015
Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation
Jeong Su Park, Dong Hoon Kang, Da Hyun Lee, Soo Han Bae
SJR Q2Biochemical and Biophysical Research CommunicationsOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
15
Article|29 citations·2016
p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death
Jeong Su Park, Sue Young Oh, Da Hyun Lee, Yu Seol Lee, Su Haeng Sung, Hye Won Ji, Moon Joo Lee, Yong‐ho Lee, Sue Goo Rhee, Soo Han Bae
SJR Q2Free Radical ResearchOA

Endoplasmic reticulum (ER) stress is triggered by various cellular stresses that disturb protein folding or calcium homeostasis in the ER. To cope with these stresses, ER stress activates the unfolded protein response (UPR) pathway, but unresolved ER stress induces reactive oxygen species (ROS) accumulation leading to apoptotic cell death. However, the mechanisms that underlie protection from ER stress-induced cell death are not clearly defined. The nuclear factor erythroid 2-related factor 2 (N

EpidemiologyMedicine

Research Areas

Molecular BiologyEpidemiologyPulmonary and Respiratory MedicineSurgeryHematologyEndocrinology, Diabetes and Metabolism

Soo Han Baeの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。